Paper Details
- Home
- Paper Details
Hyposensitization trial using salazosulfapyridine in a case of mesalamine intolerance.
Author: ItaniKenji, SogaKoichi
Original Abstract of the Article :
A 47-year-old Japanese man was diagnosed with pancolitis-type ulcerative colitis. He was treated with mesalamine in a pH-dependent release form. On day 16 of administration, he was admitted because of fever and abdominal pain. We diagnosed his symptoms to be the side effects of mesalamine. Hyposensi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s12328-019-00985-9
データ提供:米国国立医学図書館(NLM)
Salazosulfapyridine for Mesalamine Intolerance
Ulcerative colitis, a chronic inflammatory bowel disease, can pose significant challenges for individuals seeking effective treatment. This case report describes a rare instance of mesalamine intolerance, a common medication for ulcerative colitis, and the successful use of salazosulfapyridine as an alternative therapy. The patient experienced allergic reactions to mesalamine but responded favorably to salazosulfapyridine, highlighting the importance of individualized treatment approaches.Salazosulfapyridine: A Viable Alternative for Mesalamine Intolerance
This case report demonstrates the potential of salazosulfapyridine as an effective alternative treatment for individuals with mesalamine intolerance. This finding emphasizes the importance of identifying and addressing individual patient needs to ensure optimal treatment outcomes.A Journey Through the Desert of Ulcerative Colitis Treatment
Imagine a traveler navigating a vast and unforgiving desert, seeking a path to relief from the scorching heat and arid conditions. Similarly, individuals with ulcerative colitis often face a challenging journey in finding effective treatments that alleviate their symptoms. This case report highlights the importance of identifying individual responses to medications and tailoring treatment plans accordingly.Dr. Camel's Conclusion
This case report underscores the importance of personalized medicine in treating complex conditions like ulcerative colitis. While mesalamine is often a preferred treatment, individuals may experience intolerance or adverse effects. In such cases, alternative therapies like salazosulfapyridine can offer a viable path to relief. The journey to optimal health often requires careful consideration of individual needs and responses to treatment.Date :
- Date Completed 2020-04-20
- Date Revised 2020-04-20
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.